Association of statins with quality of life and olfaction in patients with chronic rhinosinusitis

Int Forum Allergy Rhinol. 2022 Feb;12(2):237-239. doi: 10.1002/alr.22880. Epub 2021 Sep 12.

Authors

Ryan A Rimmer¹, Jess C Mace¹, Amarbir Gill², Jeremiah Alt², Kara Detwiller¹, Mathew Geltzeiler¹, Timothy L Smith¹, Nyssa Fox Farrell³

Affiliations

¹ Department of Otolaryngology Head and Neck Surgery, Oregon Sinus Center, Oregon Health and Science University, Portland, OR.
² Division of Otolaryngology Head and Neck Surgery, Department of Surgery, University of Utah, Salt Lake City, UT.
³ Department of Otolaryngology Head and Neck Surgery, Washington University in St. Louis, St. Louis, MO.

PMID: 34510817
DOI: 10.1002/alr.22880

No abstract available

Keywords: cohort studies; hydroxymethylglutaryl-CoA reductase inhibitors; pilot projects; quality of life; sinusitis; smell.

MeSH terms

Chronic Disease
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Nasal Polyps* / complications
Nasal Polyps* / drug therapy
Olfaction Disorders* / complications
Quality of Life
Rhinitis* / complications
Rhinitis* / drug therapy
Sinusitis* / complications
Sinusitis* / drug therapy
Smell

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Grants and funding